Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126715961 | 12671596 | 1 | I | 20160816 | 20160822 | 20160822 | EXP | FR-STRIDES ARCOLAB LIMITED-2016SP012043 | STRIDES | 0.00 | Y | 0.00000 | 20160822 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126715961 | 12671596 | 1 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | 0 | |||||||||||
| 126715961 | 12671596 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 126715961 | 12671596 | 3 | PS | TACROLIMUS. | TACROLIMUS | 1 | UNK | 90687 | |||||||||||
| 126715961 | 12671596 | 4 | C | GANCICLOVIR. | GANCICLOVIR | 1 | UNK | 0 | |||||||||||
| 126715961 | 12671596 | 5 | C | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126715961 | 12671596 | 1 | Immunosuppression |
| 126715961 | 12671596 | 2 | Immunosuppression |
| 126715961 | 12671596 | 3 | Immunosuppression |
| 126715961 | 12671596 | 4 | Cytomegalovirus infection |
| 126715961 | 12671596 | 5 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126715961 | 12671596 | DE |
| 126715961 | 12671596 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126715961 | 12671596 | Anuria | |
| 126715961 | 12671596 | Coagulopathy | |
| 126715961 | 12671596 | Haemodynamic instability | |
| 126715961 | 12671596 | Hypercapnia | |
| 126715961 | 12671596 | Hyperkalaemia | |
| 126715961 | 12671596 | Hypoxia | |
| 126715961 | 12671596 | Metabolic disorder | |
| 126715961 | 12671596 | Multiple organ dysfunction syndrome | |
| 126715961 | 12671596 | Orthopnoea | |
| 126715961 | 12671596 | Pulmonary oedema | |
| 126715961 | 12671596 | Pyrexia | |
| 126715961 | 12671596 | Renal failure | |
| 126715961 | 12671596 | Respiratory acidosis | |
| 126715961 | 12671596 | Respiratory distress | |
| 126715961 | 12671596 | Respiratory failure | |
| 126715961 | 12671596 | Systemic inflammatory response syndrome | |
| 126715961 | 12671596 | Toxoplasmosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |